Role of Foxo1 gene expression in mechanism of antihypertrophic action of metformin in cardiomyocytes
Journal Title: Міжнародний ендокринологічний журнал - Year 2018, Vol 14, Issue 7
Abstract
Background. Diabetic cardiomyopathy is the leading cause of mortality in patients with type 2 diabetes mellitus. Hypertrophy of cardiomyocytes is one of the main pathomorphological signs of diabetic cardiomyopathy development. Metformin, the first-line drug for the treatment of type 2 diabetes mellitus, along with hypoglycaemic effects, exerts cardioprotective effects. However, the mechanism of metformin action in cardiomyocytes remains unclear. The purpose of the study was to investigate the role of Foxo1 gene expression in the mechanism of antihypertrophic action of metformin in cardiomyocytes. Materials and methods. H9C2 cells were transfected with siRNA Fохо1 and siRNA negative control. Cells were deprived in 0% medium for 24 hours, treated with metformin (5mM) 30 min before cell stress, then put into hypoxic chamber for 16 hours and reoxygenated for 4 hours. Cell area was quantified using ImageJ. Knockdown efficiency was confirmed by real time polymerase chain reaction. Results. At the normal functioning of Fохо1 gene, metformin has the expressed antihypertrophic action under hypoxia. However, blocking Fохо1 gene expression deprives preparation of this effect and causes the hypertrophy of Н9С2 cells in all conditions of the experiment. Conclusions. The strong hypertrophic response in the group of H9C2 cells transfected with siRNA Foxo1 cultured under hypoxia with metformin treatment may be a result of following mechanisms: a) metformin prevents hypertrophy through Foxo1 pathway, thus, Foxo1 silencing totally blocked metformin protective effects on H9C2 hypertrophy; b) metformin protects against hypoxia independently of Foxo1 pathway, therefore, strong hypertrophy of metformin-treated cells incubated in hypoxia is the result of Foxo1 knockdown, a potent hypertrophic stimulus. Consequently, further investigations are still required to clarify the mechanisms by which metformin exerts its cardioprotective effects.
Authors and Affiliations
N. V. Pasiechko, H. Ya. Loi, M. M. Korda, O. M. Oleshchuk
Keywords
Related Articles
- EP ID EP432728
- DOI 10.22141/2224-0721.14.7.2018.148779
- Views 49
- Downloads 0
Frederick Banting and Insulin Discovery (75th Anniversary of Tragic Death)
The article has been written in order to commemorate Canadian scientist Frederick Banting, the discoverer of insulin. There are briefly enlightened biography of the scientist and a history of insulin discovery. There is...
Anesthetic Management of Pheochromocytomas in a Specialized Endocrinology Center
Objective: the introduction of modern anesthetic management of patients with pheochromocytoma in a specialized endocrinology center using the algorithm of staged perioperative hemodynamic monitoring. Materials and method...
Influence of Overweight and Obesity on Reproductive Health and Carrying of a Pregnancy
The lecture considers the influence of obesity in women of reproductive age on somatic and reproductive problems that results in the decline of fertility. Women with obesity in comparison to the women with normal body we...
Testosterone and Quality of Women’s Life (Literature Review)
Sexual desire disorder is a common clinical problem that may have a very negative impact on a woman’s quality of life. Diagnosis and treatment are challenging, as one must keep in mind the complex web of factors influenc...
Ways for Improvement of Medical Care Provision to the in Patients with Thyroid and Concomitant Pathology
In research it was established prevalence and nature of concomitant diseases in patients with different thyroid pathology, hospitalized in endocrinology in-patient departments, volume and character of carried out therapy...